Biosimilars Immunology Roundup for July 2023—Podcast Edition


On this episode, we’re giving a rundown of some of the biggest stories in the immunology space regarding biosimilars, like the launch of 7 adalimumab biosimilars, the release of multiple market trend reports, and clinical trial results on traditionally bypassed disease states.

Related Videos
Julie Reed, executive director of the Biosimilars Forum
© 2023 MJH Life Sciences

All rights reserved.